DK3119887T3 - Forbedrede korte interfererende ribonukleinsyremolekyler - Google Patents

Forbedrede korte interfererende ribonukleinsyremolekyler Download PDF

Info

Publication number
DK3119887T3
DK3119887T3 DK15711195.6T DK15711195T DK3119887T3 DK 3119887 T3 DK3119887 T3 DK 3119887T3 DK 15711195 T DK15711195 T DK 15711195T DK 3119887 T3 DK3119887 T3 DK 3119887T3
Authority
DK
Denmark
Prior art keywords
acid molecules
ribonucleic acid
short interfering
interfering ribonucleic
improved short
Prior art date
Application number
DK15711195.6T
Other languages
English (en)
Inventor
Oommen Varghese
Oommen Oommen
Original Assignee
Oommen Varghese
Oommen Oommen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oommen Varghese, Oommen Oommen filed Critical Oommen Varghese
Application granted granted Critical
Publication of DK3119887T3 publication Critical patent/DK3119887T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088Compounds having three or more nucleosides or nucleotides
    • A61K31/713Double-stranded nucleic acids or oligonucleotides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/111General methods applicable to biologically active non-coding nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/11Antisense
    • C12N2310/111Antisense spanning the whole gene, or a large part of it
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/14Type of nucleic acid interfering nucleic acids [NA]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2320/00Applications; Uses
    • C12N2320/50Methods for regulating/modulating their activity
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK15711195.6T 2014-03-20 2015-03-20 Forbedrede korte interfererende ribonukleinsyremolekyler DK3119887T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE1450312 2014-03-20
PCT/EP2015/056012 WO2015140330A1 (en) 2014-03-20 2015-03-20 Improved small interfering ribonucleic acid molecules

Publications (1)

Publication Number Publication Date
DK3119887T3 true DK3119887T3 (da) 2019-05-20

Family

ID=52697435

Family Applications (1)

Application Number Title Priority Date Filing Date
DK15711195.6T DK3119887T3 (da) 2014-03-20 2015-03-20 Forbedrede korte interfererende ribonukleinsyremolekyler

Country Status (5)

Country Link
US (1) US20170137808A1 (da)
EP (1) EP3119887B1 (da)
DK (1) DK3119887T3 (da)
ES (1) ES2727078T3 (da)
WO (1) WO2015140330A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201516685D0 (en) * 2015-09-21 2015-11-04 Varghese Oommen P And Oommen Oommen P Nucleic acid molecules with enhanced activity
US11260134B2 (en) 2016-09-29 2022-03-01 National University Corporation Tokyo Medical And Dental University Double-stranded nucleic acid complex having overhang
WO2023207615A1 (zh) * 2022-04-26 2023-11-02 南京明德新药研发有限公司 一类含由天然核苷酸组成突出端的双链RNAi化合物
CN119614573B (zh) * 2024-12-25 2026-04-21 厦门大学 用于动物活体Zbp1基因敲低的小干扰RNA及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040259247A1 (en) * 2000-12-01 2004-12-23 Thomas Tuschl Rna interference mediating small rna molecules
EP2305812A3 (en) * 2002-11-14 2012-06-06 Dharmacon, Inc. Fuctional and hyperfunctional sirna
WO2005079533A2 (en) * 2004-02-17 2005-09-01 University Of Massachusetts Methods and compositions for mediating gene silencing
DK1888749T3 (da) * 2005-06-01 2015-01-05 Polyplus Transfection Oligonukleotider til RNA-interferens samt biologiske anvendelser deraf
EP2152870A2 (en) * 2007-05-02 2010-02-17 Sirna Therapeutics Inc. Rna interference mediated inhibition of cyclic nucleotide type 4 phosphodiesterase (pde4b) gene expression using short interfering nucleic acid (sina)
CA2746527A1 (en) * 2008-09-22 2010-03-25 Rxi Pharmaceuticals Corporation Rna interference in skin indications
EP2756845B1 (en) * 2009-04-03 2017-03-15 Dicerna Pharmaceuticals, Inc. Methods and compositions for the specific inhibition of KRAS by asymmetric double-stranded RNA
DK2631291T3 (da) * 2010-10-22 2019-06-11 Olix Pharmaceuticals Inc Nukleinsyremolekyler, der inducerer rna-interferens, og anvendelser deraf

Also Published As

Publication number Publication date
ES2727078T3 (es) 2019-10-14
WO2015140330A1 (en) 2015-09-24
EP3119887A1 (en) 2017-01-25
EP3119887B1 (en) 2019-02-20
US20170137808A1 (en) 2017-05-18

Similar Documents

Publication Publication Date Title
DK3341482T3 (da) Kunstige nukleinsyremolekyler
PL3118311T3 (pl) Antysensowny kwas nukleinowy
HUE049405T2 (hu) Nukleáz-közvetített DNS-összeállítás
DK3094731T3 (da) Saccharidmodificerede nukleinsyremolekyler
SG11201704681QA (en) Artificial nucleic acid molecules
DK3234132T3 (da) Ligand-modificerede dobbeltstrengede nukleinsyrer
DK4023249T3 (da) Nukleinsyrevacciner
EP3171975C0 (en) CATALYSTS
DK3351633T3 (da) Antisense-nukleinsyre
EP3286549A4 (en) BIOSENSOR
DK3105250T3 (da) Multispecifikke iga-bindingsmolekyler
EP3227659C0 (en) THAWING PROCESSES
DE112015005628A5 (de) Steckverbinder
EP3156789C0 (en) BIOSENSOR
DK3242685T3 (da) Cxcr4-bindende molekyler
DK3237432T3 (da) Proteinfremstilling
IL254413B (en) Cell-free production of ribonucleic acid
DK2952752T3 (da) Afbøjnings-rørbøjning
EP3387414A4 (en) BIOSENSOR
EP3371575A4 (en) BIOSENSOR
DE202014104222U8 (de) Steckverbinder
SG11201507104WA (en) Novel nucleic acid molecules
EP3141244C0 (en) EMULSIONS COMPRISING SILICIC ACID
DK3125867T3 (da) Hyperosmolær hyaluronsyresammensætning
DK3119887T3 (da) Forbedrede korte interfererende ribonukleinsyremolekyler